BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 12194996)

  • 1. Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation.
    Vo QN; Geradts J; Gulley ML; Boudreau DA; Bravo JC; Schneider BG
    J Clin Pathol; 2002 Sep; 55(9):669-75. PubMed ID: 12194996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori and EBV in gastric carcinomas: methylation status and microsatellite instability.
    Ferrasi AC; Pinheiro NA; Rabenhorst SH; Caballero OL; Rodrigues MA; de Carvalho F; Leite CV; Ferreira MV; Barros MA; Pardini MI
    World J Gastroenterol; 2010 Jan; 16(3):312-9. PubMed ID: 20082476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1.
    Geddert H; Zur Hausen A; Gabbert HE; Sarbia M
    Anal Cell Pathol (Amst); 2010; 33(3):143-9. PubMed ID: 20978327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of p16/CDKN2A tumor suppressor protein in gastric adenocarcinoma is associated with Epstein-Barr virus and anatomic location in the body of the stomach.
    Schneider BG; Gulley ML; Eagan P; Bravo JC; Mera R; Geradts J
    Hum Pathol; 2000 Jan; 31(1):45-50. PubMed ID: 10665912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDKN2A promoter methylation in gastric adenocarcinomas: clinical variables.
    Vo QN; Geradts J; Boudreau DA; Bravo JC; Schneider BG
    Hum Pathol; 2002 Dec; 33(12):1200-4. PubMed ID: 12514789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1.
    Geddert H; zur Hausen A; Gabbert HE; Sarbia M
    Cell Oncol (Dordr); 2011 Jun; 34(3):209-14. PubMed ID: 21538028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced expression and promoter methylation of p16 gene in Epstein-Barr virus-associated gastric carcinoma.
    Osawa T; Chong JM; Sudo M; Sakuma K; Uozaki H; Shibahara J; Nagai H; Funata N; Fukayama M
    Jpn J Cancer Res; 2002 Nov; 93(11):1195-200. PubMed ID: 12460459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P16 protein abnormality in Epstein-Barr virus-associated gastric carcinomas.
    Ojima H; Saito K; Yamauchi H; Yamaki E; Idetu A; Hosouchi Y; Nishida Y; Tukada K; Kato H; Kuwano H
    Anticancer Res; 2006; 26(2A):933-7. PubMed ID: 16619489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
    He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
    Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter hypermethylation of E-cadherin and its abnormal expression in Epstein-Barr virus-associated gastric carcinoma.
    Sudo M; Chong JM; Sakuma K; Ushiku T; Uozaki H; Nagai H; Funata N; Matsumoto Y; Fukayama M
    Int J Cancer; 2004 Mar; 109(2):194-9. PubMed ID: 14750169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing and CpG island methylation of GSTP1 is rare in ordinary gastric carcinomas but common in Epstein-Barr virus-associated gastric carcinomas.
    Kim J; Lee HS; Bae SI; Lee YM; Kim WH
    Anticancer Res; 2005; 25(6B):4013-9. PubMed ID: 16309193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma.
    Ushiku T; Chong JM; Uozaki H; Hino R; Chang MS; Sudo M; Rani BR; Sakuma K; Nagai H; Fukayama M
    Int J Cancer; 2007 Jan; 120(1):60-6. PubMed ID: 17058198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma.
    Kang GH; Lee S; Kim WH; Lee HW; Kim JC; Rhyu MG; Ro JY
    Am J Pathol; 2002 Mar; 160(3):787-94. PubMed ID: 11891177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus and gastric carcinoma.
    Fukayama M
    Pathol Int; 2010 May; 60(5):337-50. PubMed ID: 20518883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implication of molecular subtypes and response to neoadjuvant chemotherapy in 760 gastric carcinomas: role of Epstein-Barr virus infection and high- and low-microsatellite instability.
    Kohlruss M; Grosser B; Krenauer M; Slotta-Huspenina J; Jesinghaus M; Blank S; Novotny A; Reiche M; Schmidt T; Ismani L; Hapfelmeier A; Mathias D; Meyer P; Gaida MM; Bauer L; Ott K; Weichert W; Keller G
    J Pathol Clin Res; 2019 Oct; 5(4):227-239. PubMed ID: 31206244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes.
    Matsusaka K; Kaneda A; Nagae G; Ushiku T; Kikuchi Y; Hino R; Uozaki H; Seto Y; Takada K; Aburatani H; Fukayama M
    Cancer Res; 2011 Dec; 71(23):7187-97. PubMed ID: 21990320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDKN2A promoter methylation is related to the tumor location and histological subtype and associated with Helicobacter pylori flaA(+) strains in gastric adenocarcinomas.
    Alves MK; Lima VP; Ferrasi AC; Rodrigues MA; De Moura Campos Pardini MI; Rabenhorst SH
    APMIS; 2010 Apr; 118(4):297-307. PubMed ID: 20402675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of Epstein--Barr virus infection as detected by messenger RNA for EBNA 1 in histologically proven gastric adenocarcinoma in patients presenting to a tertiary care center in South India.
    Rymbai ML; Ramalingam VV; Samarasan I; Chandran BS; Mathew G; Jerobin J; Abraham AM; Sachithanandham J; Kannangai R
    Indian J Med Microbiol; 2015; 33(3):369-73. PubMed ID: 26068337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of p16/CDKN2A protein in Epstein-Barr virus-associated gastric carcinoma.
    Koriyama C; Kitajima S; Nomoto M; Sueyoshi K; Itoh T; Eizuru Y; Yonezawa S; Akiba S
    Oncology; 2004; 67(1):81-7. PubMed ID: 15459500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epstein-Barr virus infection and p16(INK4a) overexpression in gastric adenocarcinoma].
    Wang P; Zhang Q; Yang JF; Cheng ZN; Zhang K; Yu DH
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):244-6. PubMed ID: 19105332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.